Lv4
710 积分 2023-09-05 加入
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles
8小时前
已完结
In vivo Gene Writing with engineered retrotransposons
9小时前
已完结
Gene editing using large insertions
9小时前
待确认
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
NCCN CNS Tumor Guidelines Update for 2024
2个月前
已完结
Blood‐brain barrier transport using a high affinity, brain‐selective VNAR antibody targeting transferrin receptor 1
4个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
4个月前
已完结
The clinical landscape of CAR NK cells
4个月前
已完结
皖公网安备34019202002308
